Search
for
Sort by
Research 151–180 of 1000+
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- Alopecia Areata: Current and Emerging Therapies
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- When hair dig into the brain, JAKi , may help!
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Title Choice of treatment for severe forms of alopecia areata (case reports)
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Mechanisms of autophagy and their implications in dermatological disorders
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Janus kinase inhibitors for alopecia areata: A narrative review
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention